SecBot SecBot

UROY

Uranium Royalty Corp.
Nasdaq· CIK 0002143673 Nuclear & Fusion
$3.40 −0.03 (−0.73%)
Oct 26 4:00 PM ET · prev $3.43
Market cap
$1.3B
Small cap
Consensus
Buy
88% Buy or better · 8 analysts
Median target
🔒 Subscribers only
1 year
−16.5%
from $4.08 · Oct 27
30 days
−14.9%
from $4.00
52-week range
$2.61–5.46
−38% from high · low Jul 16
Avg volume 20D
2.65M
shares / day
Short interest
12.11M
≈3.2% of shares · +132.1%
Days to cover
2.3
at average volume
Insider net
+$43.3K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3
Strongest BULLISH Uranium Royalty Corp. reported Q1 FY2027 results with net income of $16.3M ($0.10 diluted EPS), a 900%…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $43.3K at an average $3.13. No open-market sales. Price is 9% above their cost.

  • InstitutionsBEARISH

    Q2 2026: 7 added (0 new), 16 trimmed or exited.

  • AnalystsBULLISH

    7 of 8 rate it Buy or better.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.010 → −$0.014 over 90 days.

  • Short sellersBUILDING

    Short interest +132.1% to 12.11M shares. 2.3 days to cover, ≈3.2% of shares.

  • TrendDOWNTREND

    17% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCDOUBLED1,713,479$4.8M
JANE STREET GROUP, LLCADD1,583,759$4.4M
Vident Advisory, LLCTRIM1,139,677$3.2M
UBS Group AGADD584,664$1.6M
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED563,337$1.6M
HRT FINANCIAL LPDOUBLED482,378$1.3M
CITADEL ADVISORS LLCTRIM462,854$1.3M
GOLDMAN SACHS GROUP INCADD285,455$793.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts
Buy 88% rate it Buy or better
Strong Buy2Buy5Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 19, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Jul 16, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$43.3K
bought · 1 insider
$0
sold · 0 insiders
+8.9%
vs their $3.13 cost
DateInsiderTypeValue
Jul 30, 2026
MELBYE SCOTT
Chief Executive Officer
BUY$12.5K
Jul 30, 2026
MELBYE SCOTT
Chief Executive Officer
BUY$12.5K
Jul 30, 2026
MELBYE SCOTT
Chief Executive Officer
BUY$18.3K

Earnings setup

Estimates
−$0.01
EPS estimate, this quarter
−240%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.01-$0.01–-$0.01—$0.00
Next Q-$0.01-$0.01–-$0.01—$0.00
Current FY$0.11$0.11–$0.11+1528.6%$147.6M
Next FY$0.01$0.01–$0.01-66.7%$0.00

Short side

FINRA· Sep 30, 2026
12,109,782
shares short
+132.1%
vs prior settlement
2.3
days to cover
≈3.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 SEC
Uranium Royalty Corp. filed an S-1 registration statement to register up to 226,719,982 shares of common stock for…
S-1 — Impact 6/10
Sep 30, 2026 Short interest report
Short Interest: UROY up 132% to 12.1M shares
Settlement 2026-09-30 | Days to cover: 2.25 | ≈3.21% of shares outstanding (est.)
Sep 14, 2026 SEC
Uranium Royalty Corp. reported Q1 FY2027 results with net income of $16.3M ($0.10 diluted EPS), a 900% increase YoY…
PRESS-RELEASE — Impact 8/10
Aug 28, 2026 SEC
No summary provided
10-K/A — Impact 5/10
Jul 30, 2026 Insider
MELBYE SCOTT bought 4,000 shares
Chief Executive Officer @ $3.12 ($12.5K)
Jul 30, 2026 Insider
MELBYE SCOTT bought 4,000 shares
Chief Executive Officer @ $3.13 ($12.5K)
Jul 30, 2026 Insider
MELBYE SCOTT bought 5,850 shares
Chief Executive Officer @ $3.13 ($18.3K)
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
1,713,479 shares ($4.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 30, 2026
Short interest
Short Interest: UROY up 132% to 12.1M shares
Settlement 2026-09-30 | Days to cover: 2.25 | ≈3.21% of shares outstanding (est.)
Sep 14, 2026
Earnings
Uranium Royalty Reports Results for the First Quarter of Fiscal Year 2027
LAKEWOOD, Colo., Sept. 14, 2026 /PRNewswire/ -- Uranium Royalty Corp. (NASDAQ: UROY) ("UROY" or the "Company") is pleased to announce the filing of…
Aug 11, 2026
Reg SHO list
Reg SHO Threshold: UROY exited the threshold list
URANIUM RTY CORP DEL COM | On list since 2026-08-04
Aug 7, 2026
Press release
Uranium Royalty Appoints New Directors to the Board
LAKEWOOD, Colo., Aug. 7, 2026 /PRNewswire/ -- Uranium Royalty Corp. (NASDAQ: UROY) ("URC" or the "Company") today announced the appointment of Kevin…
Aug 4, 2026
Reg SHO list
Reg SHO Threshold: UROY entered the threshold list
URANIUM RTY CORP DEL COM | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and ≥0.5% of shares outstanding

SecBot reports

8 filings · 5 bullish · 1 bearish · 2 neutral
All UROY filing & press-release reports (8)